卒中全球精选文摘订阅_爱唯医学网 http://www.elseviermed.cn/drc/GlobalAbstract/apoplexy 爱唯医学网卒中资源中心是卒中相关资讯的综合平台,致力于为广大医生和科研工作者提供最专业、最有价值的卒中相关信息,内容覆盖卒中领域的国外最新进展、期刊发表、临床指南、原版图书介绍、病例讨论、会议报道、国内外医学专家学术成果等,以及常用药物、会议预告等实用信息查询。 西洛他唑与阿司匹林用于卒中二级预防的Meta-分析。 http://www.elseviermed.cn/article/detail/Helo_he_azole_and_Meta__analysis_of_aspirin_for_secondary_prevention_of_stroke 2013/8/9 14:59:58 Dinicolantonio JJ, Lavie CJ, Fares H, Menezes AR, 支架置入术与强化药物治疗颅内动脉狭窄的比较 http://www.elseviermed.cn/article/detail/Stent_placement_and_strengthening_drug_treatment_of_intracranial_artery_stenosis_comparison 2012/6/15 16:27:39 Chimowitz, M...I..., for the SAMMPRIS Trial Invest 脑死亡:采用动脉自旋标记评估脑血流 http://www.elseviermed.cn/article/detail/Brain_death_the_artery_spin_mark_assessment_of_the_cerebral_blood_flow 2012/4/20 16:25:38 Yun Sohn Yoon 置入支架与积极药物治疗在颅内动脉狭窄治疗中的比较 http://www.elseviermed.cn/article/detail/Inserting_drugs_in_the_treatment_of_intracranial_artery_stenosis_comparison 2012/4/19 11:00:23 Chimowitz for the SAMMPRIS Trial Investigators 达比加群用于房颤患者卒中预防的成本效益 http://www.elseviermed.cn/article/detail/To_add_group_than_for_stroke_in_patients_with_atrial_fibrillation_in_the_prevention_of_cost_effectiveness Background:Recent studies have investigated alternatives to warfarin for stroke prophylaxis in patients with atrial fibrillation (AF), but whether these alternatives are cost-effective is unknown. Methods and Results:On the basis of the results from Randomized Evaluation of Long Term Anticoagulation Therapy (RE-LY) and other trials, we developed a decision-analysis model to compare the cost and qu... 2012/3/21 14:12:55 Shah Gage 使用他汀类药物与冠状动脉疾病女性患者出现房颤的风险下降有关:HERS试验 http://www.elseviermed.cn/article/detail/Use_of_statins_and_coronary_artery_disease_in_women_with_a_decreased_risk_of_atrial_fibrillation_on_HERS_test Objective: To determine the efficacy of statin treatment in atrial fibrillation (AF) prevention in women.Design: Cohort study using data obtained in the Heart and Estrogen/Progestin Replacement Study (HERS).Setting: Secondary analysis of a multicentre, randomised controlled clinical trial.Patients: 2673 Postmenopausal women with coronary disease.Main outcome measures: AF prevalence at baseline and... 2010/5/18 16:36:00 Pellegrini CN, Vittinghoff E, Lin F